Font Size:
a
A
A
Keyword [neuromyelitis optica spectrum disorder (NMOSD)]
Result: 1 - 5 | Page: 1 of 1
1.
The Expression And Clinical Significance Of Interleukin-36? In The Serum And Cerebrospinal Fluid Of Patients With Neuromyelitis Optica Spectrum Disorder
2.
Study Of Multiple Sclerosis And Neuromyelitis Optica Spectrum Disorder-Associated Risk Variant Of The GTF2I Loci Rs117026326
3.
Preliminary Observation Of Efficacy And Safety Of 15 Patients With Neuromyelitis Optic Spectrum Disorder Treated With Rituximab
4.
Short-term Effectiveness And Safety Of Three Treatment Options For The Acute Phase Of Neuromyelitis Optica Spectrum Disorders
5.
Clinical Characteristics Of Neuromyelitis Optica Spectrum Disorder(NMOSD)
<<First
<Prev Next>
Last>>
Jump to
